Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma

We've detected a paper from Cell Communication and Signaling that cites a retracted paper post-retraction. Citing paper: https://t.co/Zi6iHvR1fQ Retracted paper: https://t.co/PaVMAut6t8

@adamfeuerstein "Inspiring ,statistically significant,long-term survival greatly improved, first study to succeed prolonging the OS of rGBM in the past 27 years, sure to be one of the landmark clinical trials for GBM +rGBM",great potential value for clinic

A Review published in Cell Communication and Signaling summarizes the immunological characteristics of the central nervous system and glioblastoma and discusses the mechanism of each novel tumor vaccine for recurrent glioblastoma. https://t.co/5gEYUX6xyf

RT @sharpie510: "This has been the first study to succeed in prolonging the OS of rGBM in the past 27 years, which would sure to be one of…